News Archives

News Archives

Avivagen Announces Six Tonne Order of OxC-betaTM Livestock from New Customer in Mexico

Significant and ongoing order complements previous ten tonne order from established customer Industrias Melder Significant and ongoing order complements previous ten tonne order from established customer Industrias Melder Ottawa, ON / Business Wire/ January 26, 2021 / – Avivagen Inc.  (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and commercializing products for livestock, …Read More

Avivagen Inc. Announces Results for Fiscal Year Ending October 31, 2020

Ottawa, ON /Business Wire/ December 16, 2020 / — Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen” or the “Company”) today reported its audited financial results for the fiscal year ended October 31, 2020. Unless otherwise noted, all figures are in Canadian currency. “By all measures, Avivagen achieved considerable regulatory, customer, corporate and financial success in 2020,” said …Read More

Avivagen Announces Expansion of Non-Dilutive Financing in Support of Increased Product Sales

Ottawa, ON /Business Wire/ November 25, 2020 / Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhance and support immune function, thereby supporting general health and performance, announces that given the recent significant ramp up in …Read More

Avivagen Announces TSX Venture Exchange Approval for Extension of Warrants

Ottawa, ON /Business Wire/ November 19, 2020/ – Avivagen Inc. (TSXV:VIV) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely support immune function, promote general health and performance, announces that it has received approval by the TSX Venture Exchange for the …Read More

Avivagen Inc. Announces Proposed Extension of Warrants

Ottawa, ON /Business Wire/ November 13, 2020 / Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”   or the “Corporation”),a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhance and support immune   function, thereby supporting general health and performance, announces that it will be requesting approval from …Read More

Avivagen Announces Non-Dilutive Financing in Support of Increased Product Sales

Ottawa, ON /Business Wire/ October 15, 2020 / Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhance and support immune function, thereby supporting general health and performance, announces that given the recent significant ramp up in …Read More